DiscordantClostridioides difficilediagnostic assay and treatment practice: a cross-sectional study in a tertiary care hospital, Geneva, Switzerland
BMJ OPEN(2020)
Abstract
Objectives To determine the proportion of patients who received a treatment forClostridioides difficileinfection (CDI) among those presenting a discordantC. difficilediagnostic assay and to identify patient characteristics associated with the decision to treat CDI. Design Cross-sectional study. Setting Monocentric study in a tertiary care hospital, Geneva, Switzerland. Participants Among 4562 adult patients tested forC. difficilebetween March 2017 and March 2019, 208 patients with discordant tests' results (positive nucleic acid amplification test (NAAT+)/negative enzyme immunoassay (EIA-)) were included. Main outcome measures Treatment for CDI. Results CDI treatment was administered in 147 (71%) cases. In multivariate analysis, an abdominal CT scan with signs of colitis (OR 14.7; 95% CI 1.96 to 110.8) was the only factor associated with CDI treatment. Conclusions The proportion of NAAT+/EIA- patients who received treatment questions the contribution of the EIA for the detection of toxin A/B after NAAT to limit overtreatment. Additional studies are needed to investigate if other factors are associated with the decision to treat.
MoreTranslated text
Key words
diagnostic microbiology,gastrointestinal infections,microbiology
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined